These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35994584)

  • 1. VALIDATION OF AN AUTOMATED FLUID ALGORITHM ON REAL-WORLD DATA OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION OVER FIVE YEARS.
    Gerendas BS; Sadeghipour A; Michl M; Goldbach F; Mylonas G; Gruber A; Alten T; Leingang O; Sacu S; Bogunovic H; Schmidt-Erfurth U
    Retina; 2022 Sep; 42(9):1673-1682. PubMed ID: 35994584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Quantitative Assessment of Retinal Fluid Volumes as Important Biomarkers in Neovascular Age-Related Macular Degeneration.
    Keenan TDL; Chakravarthy U; Loewenstein A; Chew EY; Schmidt-Erfurth U
    Am J Ophthalmol; 2021 Apr; 224():267-281. PubMed ID: 33359681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine.
    Mares V; Schmidt-Erfurth UM; Leingang O; Fuchs P; Nehemy MB; Bogunovic H; Barthelmes D; Reiter GS
    Br J Ophthalmol; 2024 Jun; 108(7):971-977. PubMed ID: 37775259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial intelligence-based fluid quantification and associated visual outcomes in a real-world, multicentre neovascular age-related macular degeneration national database.
    Martin-Pinardel R; Izquierdo-Serra J; De Zanet S; Parrado-Carrillo A; Garay-Aramburu G; Puzo M; Arruabarrena C; Sararols L; Abraldes M; Broc L; Escobar-Barranco JJ; Figueroa M; Zapata MA; Ruiz-Moreno JM; Moll-Udina A; Bernal-Morales C; Alforja S; Figueras-Roca M; Gómez-Baldó L; Ciller C; Apostolopoulos S; Mosinska A; Casaroli Marano RP; Zarranz-Ventura J;
    Br J Ophthalmol; 2024 Jan; 108(2):253-262. PubMed ID: 36627173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of spectral-domain and time-domain optical coherence tomography in the detection of neovascular age-related macular degeneration activity.
    Major JC; Wykoff CC; Mariani AF; Chen E; Croft DE; Brown DM
    Retina; 2014 Jan; 34(1):48-54. PubMed ID: 23764967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IMPACT OF RESIDUAL SUBRETINAL FLUID VOLUMES ON TREATMENT OUTCOMES IN A SUBRETINAL FLUID-TOLERANT TREAT-AND-EXTEND REGIMEN.
    Grechenig C; Reiter GS; Riedl S; Arnold J; Guymer R; Gerendas BS; Bogunović H; Schmidt-Erfurth U
    Retina; 2021 Nov; 41(11):2221-2228. PubMed ID: 33830960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary analysis of predicting the first recurrence in patients with neovascular age-related macular degeneration using deep learning.
    Jang B; Lee SY; Kim C; Park UC; Kim YG; Lee EK
    BMC Ophthalmol; 2023 Dec; 23(1):499. PubMed ID: 38062449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal therapies for non-neovascular age-related macular degeneration with intraretinal or subretinal fluid.
    Cuesta-Lasso M; Vieira-Barros A; Dolz-Marco R; Roig-Revert MJ; Badal J; Amselem L; Díaz-Llopis M; Gallego-Pinazo R
    Arch Soc Esp Oftalmol; 2017 Mar; 92(3):101-106. PubMed ID: 27912913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. REFRACTORY INTRARETINAL OR SUBRETINAL FLUID IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIZUBIMAB: Functional and Structural Outcome.
    Gianniou C; Dirani A; Jang L; Mantel I
    Retina; 2015 Jun; 35(6):1195-201. PubMed ID: 25650710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study.
    Saenz-de-Viteri M; Recalde S; Fernandez-Robredo P; López Gálvez MI; Arias Barquet L; Figueroa MS; García-Arumí J; García-Layana A;
    Acta Ophthalmol; 2021 Dec; 99(8):861-870. PubMed ID: 33720541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Automated Quantification of Fluid Volumes to Anti-VEGF Therapy of Neovascular Age-Related Macular Degeneration.
    Schmidt-Erfurth U; Vogl WD; Jampol LM; Bogunović H
    Ophthalmology; 2020 Sep; 127(9):1211-1219. PubMed ID: 32327254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Literature Review.
    Chaudhary V; Matonti F; Zarranz-Ventura J; Stewart MW
    Retina; 2022 Apr; 42(4):589-606. PubMed ID: 34393212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of vascular and fluid-related parameters in neovascular age-related macular degeneration using deep learning.
    Schranz M; Told R; Hacker V; Reiter GS; Reumueller A; Vogl WD; Bogunovic H; Sacu S; Schmidt-Erfurth U; Roberts PK
    Acta Ophthalmol; 2023 Feb; 101(1):e95-e105. PubMed ID: 35912717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking disease activity with optical coherence tomography angiography in neovascular age related macular degeneration using artificial intelligence.
    Schranz M; Bogunovic H; Deak G; Sadeghipour A; Reiter GS; Schmidt-Erfurth U
    Sci Rep; 2024 Aug; 14(1):19278. PubMed ID: 39164449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial versus raster spectral-domain optical coherence tomography scan patterns for detection of macular fluid in neovascular age-related macular degeneration.
    Adam MK; Rayess N; Rahimy E; Maguire JI; Hsu J
    Br J Ophthalmol; 2016 Apr; 100(4):491-4. PubMed ID: 26261232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal aflibercept efficacy in neovascular age-related macular degeneration with suboptimal response to anti-vascular endothelial growth factor-A therapy.
    Monés J; Biarnés M;
    Eur J Ophthalmol; 2020 Sep; 30(5):1082-1090. PubMed ID: 31088111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subretinal fluid may protect against macular atrophy in neovascular age-related macular degeneration: 5 years of follow-up from Fight Retinal Blindness registry.
    Sánchez-Monroy J; Nguyen V; Puzo M; Calvo P; Arruabarrena C; Monaco P; Chilov M; Keegan D; Barthelmes D; Gillies M
    Acta Ophthalmol; 2023 Jun; 101(4):457-464. PubMed ID: 36536538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial Correspondence Between Intraretinal Fluid, Subretinal Fluid, and Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration.
    Klimscha S; Waldstein SM; Schlegl T; Bogunovic H; Sadeghipour A; Philip AM; Podkowinski D; Pablik E; Zhang L; Abramoff MD; Sonka M; Gerendas BS; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4039-4048. PubMed ID: 28813577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep-learning based automated quantification of critical optical coherence tomography features in neovascular age-related macular degeneration.
    Borrelli E; Oakley JD; Iaccarino G; Russakoff DB; Battista M; Grosso D; Borghesan F; Barresi C; Sacconi R; Bandello F; Querques G
    Eye (Lond); 2024 Feb; 38(3):537-544. PubMed ID: 37670143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.